Table 1 |
|||||||||
|
Comparison of studies reviewing the positive predictive values of food specific IgE testing. |
|||||||||
|
Study |
No. subjects |
% Atopic Dermatitis |
Average Age (years) |
Study design |
Food |
Total IgE median kU/L(range) |
PPV value %/Specific IgE level (kU/L) |
Sens. for IgE level |
Spec. for IgE level |
|
|
|||||||||
|
Sampson HA and Ho DG [26] |
196 |
100% |
5.2 |
Retrospective DBPCFC in 64% |
Cow's milk |
3000 (100-40,000) |
95%/32 |
51% |
98% |
|
|
|||||||||
|
Sampson HA [25] |
62 |
61% |
3.8 |
Prospective DBPCFC in 34% |
Cow's milk |
* |
95%/15 |
57% |
94% |
|
|
|||||||||
|
Garcia-Ara C et al[58] |
170 |
23% |
0.4 |
Prospective open controlled challenge in 95% |
Cow'smilk |
* |
95%/5 |
30% |
99% |
|
|
|||||||||
|
Celik-Bilgili S et al[22] |
398 |
88% |
1.1 |
Prospective DBPCFC or open challenge in all |
Cow'smilk |
* |
90%/88.8 |
* |
* |
|
|
|||||||||
|
Sampson HA and Ho DG[26] |
196 |
100% |
5.2 |
Retrospective DBPCFC in 64% |
Hen's egg |
3000 (100-40,000) |
95%/6 |
72% |
90% |
|
|
|||||||||
|
Sampson HA [25] |
75 |
61% |
3.8 |
Prospective DBPCFC in 33% |
Hen's egg |
* |
98%/7 |
61% |
95% |
|
|
|||||||||
|
Celik-Bilgili S et al. [22] |
227 |
88% |
1.1 |
Prospective DBPCFC or open challenge in all |
Hen's egg |
* |
95%/12.6 |
* |
* |
|
|
|||||||||
|
Boyano Martinez T et al. [61] |
81 |
43% |
1.3 |
Prospective, Open controlled challenge in all |
Egg white |
40(3-597) |
94%/0.35 |
91% |
77% |
|
|
|||||||||
|
Osterballe M et al[62] |
56 |
100% |
2.2 |
Prospective, Open challenge in all |
Egg white |
* |
100%/1.5 |
60% |
100% |
|
|
|||||||||
|
Sampson HA and Ho DG [26] |
196 |
100% |
5.2 |
Retrospective DBPCFC in 64% |
Peanut |
3000 (100-40,000) |
95%/15 |
73% |
92% |
|
|
|||||||||
|
Sampson HA[25] |
68 |
61% |
3.8 |
Prospective DBPCFC in 2% |
Peanut |
* |
100%/14 |
57% |
100% |
|
|
|||||||||
|
Maloney JM et al[23] |
234 |
57% |
6.1 |
Prospective; clinical history, no challenges |
Peanut |
* |
99%/13 |
60% |
96% |
|
|
|||||||||
|
* Not provided |
|||||||||
|
Eckman et al. Allergy, Asthma & Clinical Immunology 2009 5:2 doi:10.1186/1710-1492-5-2 |
|||||||||